Tyra Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TYRA and other ETFs, options, and stocks.About TYRA
Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Its proprietary in-house discovery platform, SNÅP, enables the rapid and precise refinement of structural design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies.
CEOTodd J. Harris
CEOTodd J. Harris
Employees60
Employees60
HeadquartersCarlsbad, California
HeadquartersCarlsbad, California
Founded2018
Founded2018
Employees60
Employees60
TYRA Key Statistics
Market cap762.45M
Market cap762.45M
Price-Earnings ratio-7.60
Price-Earnings ratio-7.60
Dividend yield—
Dividend yield—
Average volume280.69K
Average volume280.69K
High today$15.38
High today$15.38
Low today$13.35
Low today$13.35
Open price$14.73
Open price$14.73
Volume211.47K
Volume211.47K
52 Week high$17.78
52 Week high$17.78
52 Week low$6.42
52 Week low$6.42
Stock Snapshot
The current Tyra Biosciences(TYRA) stock price is $14.28, with a market capitalization of 762.45M. The stock trades at a price-to-earnings (P/E) ratio of -7.60.
On 2025-11-06, Tyra Biosciences(TYRA) stock moved within a range of $13.35 to $15.38. With shares now at $14.28, the stock is trading +7.0% above its intraday low and -7.2% below the session's peak.
Trading activity shows a volume of 211.47K, compared to an average daily volume of 280.69K.
The stock's 52-week range extends from a low of $6.42 to a high of $17.78.
The stock's 52-week range extends from a low of $6.42 to a high of $17.78.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own TYRA. This list is generated using Robinhood data, and it’s not a recommendation.